Rayonier Advanced Materials is working through a key transition as it aims to increase output of higher-value cellulose specialties while dealing with new domestic capacity and tougher trade conditions. The third quarter of 2026 was projected to build on progress in the HPC business, yet the headline numbers were dominated by a large non-cash impairment in the Paperboard & High Yield Pulp segment. From what I see, the report highlights how tariffs, demand patterns, and restructuring expenses are influencing profitability, cash flow, and the broader strategy at a moment when management is reviewing options for weaker assets.
For the third quarter ended September 26, 2026, RYAM posted net sales of $383 million, up 8.5% from $353 million a year earlier though a bit shy of the roughly $389 million consensus. The GAAP net loss widened to $229 million, or $3.40 per share, versus a $4 million loss, or $0.07 per share, in the prior-year period. The main driver was $221 million in non-cash impairment charges tied to the Paperboard & High Yield Pulp segment. Stripping those out, the loss from continuing operations came to about $8 million, a 60% sequential improvement. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted EBITDA totaled $73 million. The HPC segment posted revenue of $313 million and operating income of $43 million, helped by a 19% rise in cellulose specialties average selling prices along with lower wood and logistics costs. Paperboard & High Yield Pulp revenue increased to $70 million, but the segment recorded a $224 million operating loss, largely from a $210 million non-cash impairment. Management noted roughly $2 million in tariff-related costs after the 50% U.S. tariff on Canadian paperboard took effect.
Shares of RYAM closed at $6.91 on November 3, 2026, and fell about 5% in after-hours trading as investors absorbed the wider GAAP loss and impairment. The headline miss stood in contrast to operational gains in the HPC segment, leaving a mixed picture. Sentiment stays measured as market participants balance cellulose specialties progress against restructuring costs, tariff exposure, and the ongoing strategic review.
Going forward, the pace at which RYAM can redirect production toward cellulose specialties and away from lower-margin commodity volumes will be worth watching. Management has flagged growing cellulose specialties volumes and capacity utilization for those products as a priority, given that commodity losses continue to weigh on overall performance.
The Temiscaming facility deserves close attention. Operations there were economically idled on October 3, 2026, in response to the tariff, with estimated carrying costs of $2 million to $3 million per month while idle. Any trade-policy resolution, asset sale or restructuring, or restart decision would be material.
The strategic review, now slated for completion in the first quarter of 2027, could alter the company’s portfolio and capital structure. Cash generation has improved, with nine-month operating cash flow turning positive, and the Altamaha Green Energy project at Jesup remains a longer-term factor. Demand trends in acetate and ethers markets will also influence expectations.
In my analysis process, I frequently rely on Tickeron’s AI Screener to quickly filter stocks by fundamentals, technical patterns, and sector trends. It helps surface relevant comparisons and monitor shifting dynamics in areas like materials without spending excessive time on manual screens. This kind of tool has become a regular part of how I evaluate names such as RYAM alongside traditional data sources.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RYAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 40 cases where RYAM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RYAM's RSI Oscillator exited the oversold zone, 29 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 57 cases where RYAM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for RYAM just turned positive on October 28, 2026. Looking at past instances where RYAM's MACD turned positive, the stock continued to rise in 33 of 41 cases over the following month. The odds of a continued upward trend are 80%.
Following a +4.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAM advanced for three days, in 232 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RYAM as a result. In 61 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The 50-day moving average for RYAM moved below the 200-day moving average on September 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for RYAM entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAM's P/B Ratio (2.317) is slightly higher than the industry average of (1.199). P/E Ratio (-3.191) is within average values for comparable stocks, (3.558). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (3.769). Dividend Yield (0.042) settles around the average of (0.183) among similar stocks. P/S Ratio (0.379) is also within normal values, averaging (0.578).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. RYAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the production of fibers and specialty chemicals
Industry ChemicalsMajorDiversified